Browsing Category
Pharma Industry News
4141 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
ABIONYX Pharma (ABNX) achieves sphingomyelin manufacturing breakthrough to advance CER-001 sepsis program
ABIONYX Pharma triples CER-001 sphingomyelin yield with proprietary synthesis, advancing its sepsis programme. Read the full strategic analysis.
Avacta Group (AIM: AVCT) closes oversubscribed £10m placing at 9.35% discount as AVA6103 enters clinical dosing
Avacta Group (AIM: AVCT) completes an oversubscribed £10m equity placing at 63p ahead of late-2026 AVA6103 Phase 1 data. Read the full analyst breakdown.
Aging biotech just got a real skin test and Rubedo Life Sciences may have passed the first one
Rubedo Life Sciences posted early RLS-1496 skin trial data. Read why these Phase 1 results could matter for dermatology, aging science, and biotech.
Can deeper university alliances help Propanc Biopharma, Inc. stabilize its clinical transition?
Propanc Biopharma expands university research partnerships as it enters human trials. Discover what this signals for strategy, risk, and investors.
Biocytogen just stacked two cancer bets in three days. Is its platform strategy starting to compound?
Biocytogen’s NEOK002 IND clearance and Moonlight Bio deal highlight a platform-led oncology strategy. Read what it means for growth and sentiment.
SK pharmteco alliance with Prozomix reflects rising CDMO demand for enzyme-driven synthesis platforms
SK pharmteco Inc. and Prozomix partner to scale biocatalysis for greener drug manufacturing. Discover what this means for global pharma supply chains.
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Oxford Biomedica (OXB) reports 33% revenue growth and first EBITDA profit in 2025. BMS CAR-T supply deal and Durham, NC facility acquisition reshape its CDMO strategy. Read more.
Insilico Medicine just doubled down on CNS with Tenacia. Here’s why that matters now.
Insilico Medicine has expanded its Tenacia CNS partnership in a deal worth up to $94.75 million. Read what it signals for AI drug discovery now.
Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears
Merck agrees to acquire Terns Pharmaceuticals for $6.7B, adding TERN-701 CML drug to its oncology pipeline ahead of Keytruda's 2028 patent cliff. Read the full analysis.
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Avalyn Pharma advances AP02 into Phase 2 trials, testing inhaled drug delivery as a safer IPF strategy. Discover what this means for the fibrosis market.